Cleared Traditional

K882695 - RUBBER BAND, STERILE

K882695 is an FDA 510(k) clearance for RUBBER BAND, manufactured by Bioseal. The device is a Class 1 Dental device with product code ECI cleared through the Traditional 510(k) pathway after a 108-day FDA review.

K882695 · Bioseal · Dental device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1988
Decision
108d
Days
Class 1
Risk

K882695 is an FDA 510(k) clearance for the RUBBER BAND, STERILE. Classified as Band, Elastic, Orthodontic (product code ECI), Class I - General Controls.

Submitted by Bioseal (Brea, US). The FDA issued a Cleared decision on October 13, 1988 after a review of 108 days - within the typical 510(k) review window.

This device falls under the Dental FDA review panel, regulated under 21 CFR 872.5410 - the FDA dental device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Dental review framework, consistent with the majority of Class II 510(k) submissions.

View all Bioseal devices

FDA 510(k) Submission Details - K882695

510(k) Number K882695 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 27, 1988
Decision Date October 13, 1988
Days to Decision 108 days
Submission Type Traditional
Review Panel Dental (DE)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
20d faster than avg
Panel avg: 128d · This submission: 108d
Pathway characteristics
Predicate-based equivalence.

ECI Device Classification - Class 1, General Controls

Product Code ECI Band, Elastic, Orthodontic
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 872.5410
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.